secwatch / observer
8-K filed May 15, 2024, 7:59 PM ET ticker NHC CIK 0001047335
other confidence high sentiment neutral materiality 0.15

Shareholders re-elect Abernathy and Adams; say-on-pay passes with 98% support

NATIONAL HEALTHCARE CORP

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.95

NATIONAL HEALTHCARE CORP shareholders approved Re-election of Robert G. Adams as director at the 2024-05-09 meeting.

Proposal
director election
Outcome
passed
Meeting
2024-05-09
Exact text from the filing
Adams 11,757,571 823,901 4,801 2. To consider an advisory vote on the compensation of our Named Executive Officers.
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 1.0

NATIONAL HEALTHCARE CORP shareholders approved Advisory vote on the compensation of Named Executive Officers at the 2024-05-09 meeting.

Proposal
say on pay
Outcome
passed
Meeting
2024-05-09
Exact text from the filing
For Against Abstain 12,356,288 206,294 23,691 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.95

NATIONAL HEALTHCARE CORP shareholders approved Re-election of J. Paul Abernathy, M.D. as director at the 2024-05-09 meeting.

Proposal
director election
Outcome
passed
Meeting
2024-05-09
Exact text from the filing
8,970,928 3,588,572 26,773 Robert G. Adams 11,757,571 823,901 4,801 2. To consider an advisory vote on the compensation of our Named Executive Officers.
View on SEC.gov

352 shareholder votes filed in the last 30 days. Browse all shareholder votes →

NATIONAL HEALTHCARE CORP filing history →

Source: SEC EDGAR
accession 0001437749-24-016722
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.